Welcome to RLPSecurties

Stock Quotes	Board Of Directors	Income Statement	Directors Report	Change Name	Quarterly Results
High/Low	Share Holding	Balance Sheet	Auditors Report	Book Closure	Half Yearly Results
Company Profile	MF Holding	Cash Flow	Notes to Accounts	Dividend Details	Technical Chart
Locations	Investor Returns	Ratios	Banker's/Auditor's	ADR/GDR Prices	Peer Comparision

Marksans Pharma Ltd.	Balance Sheet

NSE: MARKSANSEQ BSE: 524404ISIN: INE750C01026INDUSTRY: Pharmaceuticals

BSE

Rs 254.45

Open: 220.70

Today's Range 218.10

258.85

NSE
Rs 254.79
+34.53 (+ 13.55 %)

+34.20 (+ 13.44 %)

Prev Close: 220.25

52 Week Range 156.00

270.60

You can view the Balance Sheet for the last 5 years.

Market Cap. (Rs.)	11546.16 Cr.	P/BV	4.12	Book Value (Rs.)	61.83
52 Week High/Low (Rs.)	271/155	FV/ML	1/1	P/E(X)	30.34
Bookclosure	01/08/2025	EPS (Rs.)	8.40	Div Yield (%)	0.31

(Rs. in Crs.)

Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	1.00	1.00	1.00	1.00	1.00
No. of Equity Shares (in Lacs)	4531.60	4531.64	4531.64	4531.64	4093.14

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	45.32	45.32	45.32	45.32	40.93
Total Share Capital	45.32	45.32	45.32	45.32	40.93

Reserves and Surplus	2977.84	2421.60	2019.74	1699.85	1161.34
Total Reserves and Surplus	2977.84	2421.60	2019.74	1699.85	1161.34
Total Shareholders Funds	3023.16	2466.91	2065.05	1745.16	1202.27
Minority Interest	29.52	22.47	20.85	19.91	20.70

NON-CURRENT LIABILITIES
Deferred Tax Liabilities [Net]	5.09	3.66	10.62	15.39	17.62
Other Long Term Liabilities	270.13	269.25	190.02	65.69	41.43
Long Term Provisions	5.92	0.00	4.56	3.25	1.86
Total Non-Current Liabilities	281.13	272.91	205.20	84.33	60.91

CURRENT LIABILITIES
Short Term Borrowings	29.59	23.09	29.09	41.59	41.29
Trade Payables	336.91	305.70	268.28	230.60	200.08
Other Current Liabilities	160.27	148.56	90.53	67.48	114.12
Short Term Provisions	0.32	0.00	1.96	1.33	0.72
Total Current Liabilities	527.09	477.34	389.85	340.99	356.22

Total Capital And Liabilities	3860.90	3239.63	2680.95	2190.39	1640.10

ASSETS
NON-CURRENT ASSETS
Tangible Assets	668.81	886.41	675.71	379.64	341.59
Intangible Assets	72.97	54.62	60.73	68.17	56.69
Capital Work-In-Progress	14.78	9.00	5.38	7.25	0.70
Intangible Assets Under Development	0.00	18.11	4.04	2.62	1.88
Fixed Assets	756.56	968.14	745.85	457.69	400.86
Goodwill On Consolidation	45.26	40.93	39.50	38.49	30.03
Deferred Tax Assets [Net]	12.97	0.00	0.00	0.00	3.86
Other Non-Current Assets	323.38	26.44	33.11	18.91	4.16
Total Non-Current Assets	1138.16	1035.51	818.46	515.09	438.90


CURRENT ASSETS
Current Investments	0.00	0.74	26.99	0.54	0.44
Inventories	972.28	845.52	617.94	484.74	424.44
Trade Receivables	644.57	540.04	453.18	416.85	394.78
Cash And Cash Equivalents	989.65	704.21	673.58	714.96	349.27
OtherCurrentAssets	116.24	113.61	90.80	58.21	32.28
Total Current Assets	2722.74	2204.12	1862.49	1675.30	1201.20

Total Assets	3860.90	3239.63	2680.95	2190.39	1640.10

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	0.00	34.15	45.87	9.31	17.02

CURRENT INVESTMENTS
Current Investments Unquoted Book Value	0.00	0.74	26.99	0.00	0.00

Market

Derivatives

Mutual Fund

IPO

Quick Links

Marksans Pharma Ltd.

Balance Sheet